Ology Bioservices, Inc

Ology Bioservices was acquired by National Resilience, Inc. (Resilience) in April of 2021. For more information on available services, please visit the Resilience website at https://resilience.com. History: Ology Bioservices was founded in 1999 as an integrated biopharmaceutical company with a focus on development and manufacturing as well as having expertise in preclinical and clinical development, formulation optimization, and cGMP manufacturing of biopharmaceutical products and medical devices. From its early beginnings, the companys growth was fueled through grants and contracts from both industry and several U.S. Government (USG) agencies (NIH, DoD, NCI, BARDA). Today, the company has grown to over 185...

Upstream process development,purification process development,cell line development,analytical method transfer,analytical method development,analytical method validation,project management,regulatory compliance,21 cfr 210 and 211 (drugs),21 cfr 600,606,and 610 (biologics),21 cfr 1270 and 1271 (human cells,tissues and cellular and tissue-based products),iso 9001 (general quality systems),us government contracting,cell therapy,gene therapy,viral vectors,vaccines,oncolytic viruses,antibodies,biopharmaceutical manufacturing,and biologics

Ology bioservices, inc operates in the Biotechnology research industry.

Ology bioservices, inc's HQ phone number is +886226539898

Ology bioservices, inc's revenue is 11m - 100m

Ology bioservices, inc has 11 - 50 employees.